YU48583B - Postupak za pripremanje formulacije u obliku pilule za oralno davanje - Google Patents

Postupak za pripremanje formulacije u obliku pilule za oralno davanje

Info

Publication number
YU48583B
YU48583B YU215090A YU215090A YU48583B YU 48583 B YU48583 B YU 48583B YU 215090 A YU215090 A YU 215090A YU 215090 A YU215090 A YU 215090A YU 48583 B YU48583 B YU 48583B
Authority
YU
Yugoslavia
Prior art keywords
water
epimer
budesonide
soluble
polymer
Prior art date
Application number
YU215090A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU215090A (sr
Inventor
Ulmius Jan
Original Assignee
Aktiebolaget Draco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48583(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aktiebolaget Draco filed Critical Aktiebolaget Draco
Priority to SI9012150A priority Critical patent/SI9012150A/sl
Priority to HRP-2150/90A priority patent/HRP920632B1/xx
Publication of YU215090A publication Critical patent/YU215090A/sh
Publication of YU48583B publication Critical patent/YU48583B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
YU215090A 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje YU48583B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9012150A SI9012150A (sl) 1989-11-22 1990-11-13 Oralni pripravek za zdravljenje vnetnih črevesnih bolezni
HRP-2150/90A HRP920632B1 (en) 1989-11-22 1992-09-30 Oral composition for the treatment of inflammatory bowel deseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Publications (2)

Publication Number Publication Date
YU215090A YU215090A (sr) 1996-01-09
YU48583B true YU48583B (sh) 1998-12-23

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
YU215090A YU48583B (sh) 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje

Country Status (36)

Country Link
US (1) US6423340B1 (OSRAM)
EP (1) EP0502092B1 (OSRAM)
JP (1) JP3145111B2 (OSRAM)
KR (1) KR0179042B1 (OSRAM)
AT (1) ATE125445T1 (OSRAM)
AU (1) AU643021B2 (OSRAM)
CA (1) CA2071518C (OSRAM)
DE (1) DE69021214T2 (OSRAM)
DK (1) DK0502092T3 (OSRAM)
EG (1) EG19642A (OSRAM)
ES (1) ES2074698T3 (OSRAM)
FI (2) FI104949B (OSRAM)
GR (1) GR3017691T3 (OSRAM)
HK (1) HK51897A (OSRAM)
HR (1) HRP920632B1 (OSRAM)
HU (2) HU216836B (OSRAM)
IE (1) IE74854B1 (OSRAM)
IL (1) IL96415A (OSRAM)
IS (1) IS1858B (OSRAM)
LT (1) LT3696B (OSRAM)
LV (1) LV10183B (OSRAM)
MY (1) MY104535A (OSRAM)
NO (1) NO304010B1 (OSRAM)
NZ (1) NZ235807A (OSRAM)
PL (1) PL166506B1 (OSRAM)
PT (1) PT95946A (OSRAM)
RU (1) RU2134104C1 (OSRAM)
SA (1) SA90110123B1 (OSRAM)
SE (1) SE8903914D0 (OSRAM)
SG (1) SG54210A1 (OSRAM)
SI (1) SI9012150A (OSRAM)
TW (1) TW250435B (OSRAM)
UA (1) UA37196C2 (OSRAM)
WO (1) WO1991007172A1 (OSRAM)
YU (1) YU48583B (OSRAM)
ZA (1) ZA908777B (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
WO1994015947A1 (en) * 1993-01-08 1994-07-21 Astra Aktiebolag Novel colon- or ileum-specific steroid derivatives
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CA2271560C (en) * 1996-11-15 2003-09-23 Mayo Foundation For Medical Education And Research Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
NZ528607A (en) * 2001-03-15 2007-11-30 Enteron Pharmaceuticals Inc Method of treating inflammatory GI disorders using topically active corticosteroids to reduce symptoms without causing the side effects associated with systemic steroid administration
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
RS51707B (sr) 2002-12-12 2011-10-31 Nycomed Gmbh. Kombinacija leka sastavljena od r, r - formoterola i ciklezonida
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
ATE476185T1 (de) * 2003-09-15 2010-08-15 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
EP2143424A4 (en) * 2007-03-26 2013-07-31 Teikoku Seiyaku Kk ORAL PHARMACEUTICAL PREPARATION FOR SPECIFIC DELIVERY TO THE COLON
RU2010119041A (ru) * 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
CA2739465C (en) * 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
AU2012211968A1 (en) * 2011-02-04 2013-08-29 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z (ro) * 2011-07-07 2012-09-30 Elvira Andon Metoda de tratament al colitei ulceroase nespecifice acute
JOP20200144A1 (ar) 2012-04-30 2017-06-16 Tillotts Pharma Ag تركيبة عقار ذو إطلاق متأخر
BR112016004863B1 (pt) 2013-10-29 2022-09-20 Tillotts Pharma Ag Formulação de droga de liberação retardada
US9707182B2 (en) * 2015-09-11 2017-07-18 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
RU2750937C2 (ru) * 2016-02-09 2021-07-06 Альбирео Аб Пероральный состав холестирамина и его применение
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (OSRAM) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
FI104949B (fi) 2000-05-15
FI19991893L (fi) 1999-09-06
NO304010B1 (no) 1998-10-12
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
EP0502092B1 (en) 1995-07-26
NZ235807A (en) 1993-02-25
KR0179042B1 (ko) 1999-03-20
MY104535A (en) 1994-04-30
SG54210A1 (en) 1998-11-16
IE904170A1 (en) 1991-05-22
KR920703025A (ko) 1992-12-17
DK0502092T3 (da) 1995-12-27
WO1991007172A1 (en) 1991-05-30
PL166506B1 (pl) 1995-05-31
AU643021B2 (en) 1993-11-04
RU2134104C1 (ru) 1999-08-10
FI922325A0 (fi) 1992-05-21
HUT60630A (en) 1992-10-28
CA2071518A1 (en) 1991-05-23
TW250435B (OSRAM) 1995-07-01
ATE125445T1 (de) 1995-08-15
LTIP1751A (en) 1995-07-25
FI19991893A7 (fi) 1999-09-06
DE69021214T2 (de) 1996-01-04
JP3145111B2 (ja) 2001-03-12
EP0502092A1 (en) 1992-09-09
IL96415A (en) 1995-11-27
LV10183A (lv) 1994-10-20
SA90110123B1 (ar) 1999-06-06
ES2074698T3 (es) 1995-09-16
NO922004L (no) 1992-05-21
SI9012150A (sl) 1998-08-31
PL287844A1 (en) 1991-12-02
HRP920632A2 (en) 1995-04-30
US6423340B1 (en) 2002-07-23
IS1858B (is) 2003-03-27
YU215090A (sr) 1996-01-09
HRP920632B1 (en) 1999-10-31
AU7786491A (en) 1991-06-13
HU9201700D0 (en) 1992-08-28
LT3696B (en) 1996-02-26
PT95946A (pt) 1991-09-13
GR3017691T3 (en) 1996-01-31
JPH05501705A (ja) 1993-04-02
IE74854B1 (en) 1997-08-13
CA2071518C (en) 2002-11-12
HK51897A (en) 1997-05-02
NO922004D0 (no) 1992-05-21
HU216836B (hu) 1999-09-28
UA37196C2 (uk) 2001-05-15
IL96415A0 (en) 1991-08-16
SE8903914D0 (sv) 1989-11-22
EG19642A (en) 1995-08-30
FI922325L (fi) 1992-05-21
IS3644A7 (is) 1991-05-23
DE69021214D1 (de) 1995-08-31

Similar Documents

Publication Publication Date Title
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
KR930003114B1 (ko) 2상성의 방출 단면을 가진 제어 방출되는 경구용 제제의 제조방법
US3835221A (en) Orally administrable drug dosage form having delayed action
US3279995A (en) Shaped pellets
IE900371L (en) Modified release gemfibrozil composition
JPS6440424A (en) Delay release type acetaminophen composition for oral administration and manufacture
US4867984A (en) Drug in bead form and process for preparing same
DE1222213B (de) Spermizides Praeparat
KR900009059A (ko) 다입상의 방출 조절 경구용 조성물을 위한 과립
BR0009759A (pt) Formulação agroquìmica na forma sólida granular, e, métodos para preparação de uma mistura de pulverização e para tratamento de plantas
Khan et al. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: Influence of several parameters and coexcipients
Jalsenjak et al. Dissolution from tablets prepared using ethyl cellulose microcapsules
SK282303B6 (sk) Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky
US4115563A (en) Pharmaceutical steroid formulation
JPS5770817A (en) Polytice and its preparation
JPS54119021A (en) Carcinostatic agent
DE2251249A1 (de) Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten
US3495000A (en) Oral sustained release medicament matrix of dialdehyde starch admixed with ethyl cellulose,polyvinyl chloride or polyvinylpyrrolidone
JPS5650978A (en) Hot-melt sticking composition
JPS55122726A (en) Prolonged release drug composition
EP0222883A1 (en) Sustained release theophylline compositions and processes
US3108044A (en) Medicament of polystyrene anion exchange resin having a barbiturate adsorbed thereon
Nishihata et al. Preliminary study on sustained-release particles prepared with hydrogenated soya phospholipid and cholesterol
Lin et al. Different types of direct compressible excipients affecting the release behavior of theophylline controlled-release tablets containing Eudragit resins
DE323908C (de) Verfahren zur UEberfuehrung von OElen, Harzen, Wachsen, Balsamen, Extrakten in trockene Pulver mittels Kieselsaeure